PEAK6’s Organon & Co OGN Stock Holding History

PEAK6’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,300	Closed	-$181K	–	3125
2025 Q4	$181K	Sell	25,300 -1,500	-6%	-$11.9K	﹤0.01%	2407
2025 Q3	$286K	Hold	26,800	–	–	﹤0.01%	2352
2025 Q2	$259K	Buy	+26,800	New	+$276K	﹤0.01%	2367

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

PEAK6's OGN Position: Q1 2026 in Review

PEAK6 sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 15,078 shares — an estimated $108K sold.

PEAK6 first reported a position in OGN in Q2 2025 and held it in 3 quarters. The position peaked at $108K in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

PEAK6 reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
PEAK6 sold 15,078 Organon & Co shares in Q1 2026, an estimated $108K.
PEAK6 first reported a position in Organon & Co in Q2 2025 and held it in 3 quarters.
PEAK6's Organon & Co position peaked at $108K in Q4 2025.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.